Experimental and Theoretical Investigation of Inclusion Complexes of β-Cyclodextrin with Fingolimod

被引：3

作者：

Garibyan, A. A. ^{[1
]}

Delyagina, E. S. ^{[1
,2
]}

Antipova, M. L. ^{[1
]}

Odintsova, E. G. ^{[1
]}

Petrenko, V. E. ^{[1
]}

Terekhova, I. V. ^{[1
]}

机构：

[1] Russian Acad Sci, GA Krestov Inst Chem Solut, Ivanovo 153045, Russia

[2] Ivanovo State Univ, Ivanovo 153025, Russia

来源：

RUSSIAN JOURNAL OF PHYSICAL CHEMISTRY A | 2023年 / 97卷 / 03期

关键词：

cyclodextrin; fingolimod; complexation; solubilization; MULTIPLE; SIMULATIONS; DYNAMICS; FTY720;

D O I：

10.1134/S0036024423030135

中图分类号：

O64 [物理化学（理论化学）、化学物理学];

学科分类号：

070304 ; 081704 ;

摘要：

The solubilizing effect of beta-cyclodextrin on fingolimod, a new generation immunosuppressant, is studied for the first time. A possible 20x increase in the solubility of fingolimod due to the penetration of the hydrophobic fragment of the drug molecule into the macrocyclic cavity of the cyclodextrin is shown. Data driven H-1 NMR spectroscopy and computer modeling suggest the configuration of the resulting inclusion complexes. The constant of the complex's stability and its energy of complexation are calculated, and the formation of hydrogen bonds between fingolimod and beta-cyclodextrin is considered.

引用

页码：469 / 476

页数：8

共 45 条

[31]

Nasser A., 2019, J BASIC CLIN PHYSIOL, V30, DOI [10.1515/jbcpp-2019-0063, DOI 10.1515/JBCPP-2019-0063]

[32] A MOLECULAR-DYNAMICS METHOD FOR SIMULATIONS IN THE CANONICAL ENSEMBLE [J].

NOSE, S .

MOLECULAR PHYSICS, 1984, 52 (02) :255-268

[33] Fingolimod for Multiple Sclerosis [J].

Pelletier, Daniel ;

Hafler, David A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04) :339-347

[34] Stabilization and solubilization of difluprednate in aqueous cyclodextrin solution and its characterization for ophthalmic delivery [J].

Prajapati, Manisha ;

Loftsson, Thorsteinn .

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 69

[35] Spectrofluorimetric analysis of fingolimod via complex formation with eosin Y in its pure form, pharmaceutical preparation and biological samples [J].

Salem, Hesham ;

Elsoud, Fatma A. Abo ;

Heshmat, Dina .

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2021, 250

[36] Solubility of Cyclodextrins and Drug/Cyclodextrin Complexes [J].

Saokham, Phennapha ;

Muankaew, Chutimon ;

Jansook, Phatsawee ;

Loftsson, Thorsteinn .

MOLECULES, 2018, 23 (05)

[37] Application of Artificial Neural Networks in the Design and Optimization of a Nanoparticulate Fingolimod Delivery System Based on Biodegradable Poly(3-Hydroxybutyrate-Co-3-Hydroxyvalerate) [J].

Shahsavari, Shadab ;

Shirmard, Leila Rezaie ;

Amini, Mohsen ;

Dokoosh, Farid Abedin .

JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (01) :176-182

[38] Improving the in-vivo biological activity of fingolimod loaded PHBV nanoparticles by using hydrophobically modified alginate [J].

Shirmard, Leila Rezaie ;

Ghofrani, Mahdieh ;

Javan, Nika Bahari ;

Bayrami, Samane ;

Tavassoli, Abdollah ;

Rezaie, Amir ;

Amini, Mohsen ;

Kebriaee-zadeh, Abbas ;

Rouini, Mohammad-Reza ;

Dinarvand, Rassoul ;

Rafiee-Tehrani, Morteza ;

Dorkoosh, Farid Abedin .

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2020, 46 (02) :318-328

[39] Fingolimod (FTY720): A Recently Approved Multiple Sclerosis Drug Based on a Fungal Secondary Metabolite [J].

Strader, Cherilyn R. ;

Pearce, Cedric J. ;

Oberlies, Nicholas H. .

JOURNAL OF NATURAL PRODUCTS, 2011, 74 (04) :900-907

[40] Introduction and general overview of cyclodextrin chemistry [J].

Szejtli, J .

CHEMICAL REVIEWS, 1998, 98 (05) :1743-1753

← 1 2 3 4 5 →